Once STN DBS, Always STN DBS?-Clinical, Ethical, and Financial Reflections on Deep Brain Stimulation for Parkinson's Disease

Marwan Hariz^{1

2}

Affiliations

¹ Unit of Functional Neurosurgery UCL Institute of Neurology London United Kingdom.
² Department of Clinical Neuroscience Umeå University Umeå Sweden.

Editorial

Marwan Hariz. Mov Disord Clin Pract. 2016.

. 2016 Feb 11;3(3):285-287.

doi: 10.1002/mdc3.12292. eCollection 2016 May-Jun.

Marwan Hariz^{1

2}

¹ Unit of Functional Neurosurgery UCL Institute of Neurology London United Kingdom.
² Department of Clinical Neuroscience Umeå University Umeå Sweden.

No abstract available

Keywords: Parkinson's disease; deep brain stimulation; parkinsonian crisis; subthalamic nucleus; withdrawal syndrome.

References

1. Pollak P, Krack P. Deep‐brain stimulation for movement disorders In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders. 5th ed Philadelphia, PA: Lippincott Williams & Wilkins; 2007:653691.
1. Rajan R, Krishnan S, Kesavapisharady KK, Kishore A. Malignant subthalamic nucleus‐deep brain withdrawal syndrome in Parkinson's disease. Mov Disord Clin Pract 2016;3:288–291. - PMC - PubMed
1. Hariz MI, Johansson F. Hardware failure in parkinsonian patients with chronic subthalamic nucleus stimulation is a medical emergency. Mov Disord 2001;16:166–168. - PubMed
1. Reuter S, Deuschl G, Falk D, Mehdorn M, Witt K. Uncoupling of dopaminergic and subthalamic stimulation: life‐threatening DBS withdrawal syndrome. Mov Disord 2015;30:1407–1413. - PubMed
1. Neuneier J, Barbe MT, Dohmen C, Maarouf M, Wirths J, Fink GR, Timmermann L. Malignant deep brain stimulation‐withdrawal syndrome in a patient with Parkinson's disease. Mov Disord 2013;28:1640–1641. - PubMed